Efficacy, Safety, and Biomarker Analysis of Toripalimab Monoclonal Antibody Combined with Gemcitabine and Cisplatin Chemotherapy as Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: A Phase II Clinical Trial
1. 系统已在2026-03-06 10:26:28对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1097/JU.0000000000004993
文献链接: http://www.auajournals.org/doi/10.1097/JU.0000000000004993
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Shun Zhang; Tianhang Li; Danyan Li; Yue Yin; Wenjie Zhu; Ning Jiang; Shiwei Zhang; Rong Yang; Hongqian Guo

